The Cancer Research Institute (CRI) and Stand Up To Cancer (SU2C), in partnership with the American Association for Cancer Research (AACR), have issued a call for letters of intent from scientists and clinical investigators interested in forming the SU2C-CRI Cancer Immunology Translational Research Dream Team.
See press release here: http://cancerresearch.org/pressroom/2012/03/07/stand-up-to-cancer-immunology-dream-team-grant/
In parallel, we are preparing a special relaunch issue dedicated to Dr. Lloyd Old, who founded Cancer Immunity in 2001, which is scheduled for publication on May 1, 2012. The issue will feature a collection of personal reflections by some of Dr. Old’s closest collaborators, reflecting on Dr. Old and his work at different points throughout his career. Also included in the issue will be a set of scientific commentaries on the topic of antibodies in cancer treatment.
For more information about the relaunch issue, please see the announcement at http://bit.ly/CIrelaunch.
Cancer Immunity (ISSN 1424-9634) is an open access, peer reviewed journal of the Cancer Research Institute that publishes laboratory and clinical research papers focusing on the immune response to cancer. Visit http://www.cancerimmunity.org for more information, or to publish with us.